×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 6B: Risk-based Approach to Monitoring CR
Speaker(s)
Risk-based Approach to Monitoring CR
Sunita Zalani, PhD
Merck & Co., Inc., United States
Vice President, Regulatory Affairs, Oncology
Risk-based Approach to Monitoring CR
Chirag Trivedi
Sanofi India Limited, India
Director, Clinical Study Unit,
Have an account?